A dose-dependent response is seen with an increasing number of cardiometabolic diseases and cognitive decline.
Prevalence of risk factors for Alzheimer’s, related dementias identified
May 20, 2022
The highest prevalence seen for high blood pressure and not meeting aerobic physical activity guidelines, followed by obesity.
FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.
Inverse link found for antioxidant levels, all-cause dementia
May 04, 2022
Serum lutein+zeaxanthin and β-cryptoxanthin levels were inversely associated with incident all-cause dementia.
Dementia incidence varies by race, ethnicity
Apr 21, 2022
Among U.S. veterans, the rates of dementia were highest for Blacks and Hispanics.
Premature menopause tied to higher risk for later dementia
Mar 14, 2022
Also, early menopause was linked to an increased risk for early-onset dementia.
ASA: Myocardial infarction may hasten cognitive decline in adults
Feb 03, 2022
Participants with incident MI had significantly faster declines in global cognition, memory and executive function than those without MI
Senate committee backs Califf nomination to head FDA
Jan 14, 2022
Among those who voted against Califf’s nomination were Democrats who expressed concerns about his links to pharmaceutical companies.
Levetiracetam well-tolerated for Alzheimer’s disease
Oct 01, 2021
It does not improve primary outcome but did improve performance on certain cognitive tasks in those with epileptiform activity.
Dementia risk score linked to MRI markers of brain atrophy
Aug 26, 2021
Higher scores on the Lifestyle for Brain Health index were linked to higher volumes of white matter hyperintensities, lower scores for cognitive function.